Dr Yoon An is a head of Inflammatory Bowel Disease (IBD) clinical research at Mater Research. She is also a gastroenterologist who specialises in IBD, combining public and private practices at Mater Hospital Brisbane, Mater Private Hospital Brisbane and Mater Private Hospital Redland. She holds a senior lecturer position at the University of Queensland.
Dr An completed her Medical Science degree (BMedSc) at the University of Sydney and her Medical degree (MBBS) at the University of Queensland. She undertook her physician and advanced gastroenterology training at the Royal Brisbane and Women’s Hospital and Mater Hospital Brisbane. She completed a clinical and research fellowship in IBD at Mater Hospital Brisbane and completed executive business and leadership program at the University of Oxford Said Business School. She is currently pursuing a PhD through the University of Queensland and an MBA through Griffith University.
Dr An is a passionate advocate for optimising patient outcomes through a holistic approach to care including clinical and translational research. She is an active IBD clinician and researcher and leads the Mater IBD clinical trials unit, which is a world-leader in conducting investigator-initiated studies and sponsored clinical trials. Her own research focusses on real-world effectiveness of biologic therapy in IBD and the use of intestinal ultrasound to monitor disease activity and predict responses to therapy. She drives collaborative research projects throughout Australia and is actively involved with the Australia New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC), the Gastroenterology Network for Intestinal Ultrasound (GENIUS) and the Gastroenterological Society of Australia (GESA).
Dr An has been successful in competitive research funding from industry and was the recipient of GENIUS fellowship. She has affiliations with many Gastroenterology and IBD societies and has a national presence through conference presentations and symposia. She also serves on the Advisory Boards of Chiesi, Bristol-Myers Squibb and NPS Medicine Wise.
Current appointments
2021 – current:
- Executive Committee Member – Secretary, Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC)
2020 – current:
- Scientific Committee Member, Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC)
2020 – current:
- Board Member – Research Officer, Gastroenterology Network for Intestinal Ultrasound (GENIUS)
2020 – current:
- Executive Committee Member – IBD Liaison Officer, Young GESA Network, Gastroenterological Society of Australia (GESA)
2020 – current:
- Expert Advisory Group member, The Council of Therapeutic Advisory Groups (CATAG)
2020 – current:
- GESA representative/ A member of the Australian General Practice Accreditation, Limited (AGPAL) Content Development Group
- CCA-GESA GP Aware Program Committee, Crohn’s and Colitis Australia (CCA)
2020 – current:
- Expert Working Group Member, bDMARDs Gastroenterology Design Forum, NPS Medicine Wise
2020 – current:
- Stakeholder Panel (GESA representative), Value in Prescribing bDMARDs Program, NPS Medicine Wise